First multicenter real-world analysis of switching to next-generation enzyme replacement therapies in late-onset Pompe disease. [PDF]
Mendelsohn DH +10 more
europepmc +1 more source
Relative acidic compartment volume as a lysosomal storage disorder-associated biomarker [PDF]
Al Eisa, Nada +14 more
core +1 more source
Long-Term Open-Label Study Evaluating Oral Miglustat Treatment in Patients With Neuronal Ceroid Lipofuscinosis Type 3. [PDF]
Pietrafusa N +9 more
europepmc +1 more source
Visual Recovery and Neurological Stabilization Following Miglustat Treatment in Pediatric CLN3 Disease. [PDF]
Dutton AE +6 more
europepmc +1 more source
Characterization of liver disease in a cohort of individuals with Niemann-Pick Disease, Type C1. [PDF]
Agrawal N +8 more
europepmc +1 more source
Cipaglucosidase alfa and miglustat for treatment of late-onset Pompe disease (LOPD): A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG). [PDF]
Baker EK +4 more
europepmc +1 more source
NEO1 modulates the A1 astrocyte polarization in subarachnoid hemorrhage through the cPLA2-MAVS signaling pathway. [PDF]
Wu Y +19 more
europepmc +1 more source

